Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Colorcon
Citi
Chinese Patent Office
UBS
Baxter

Generated: March 22, 2019

DrugPatentWatch Database Preview

Litigation for REVLIMID

« Back to Dashboard

US Court Litigation for REVLIMID

Patent Trial and Appeal Board Cases for REVLIMID

Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download
5,635,517 Coalition for Affordable Drugs VI LLC ➤ Try a Free Trial 2015-05-07 2015-05-07 Celgene Corporation Inter partes review ➤ Try a Free Trial 2015-11-16 GEORGE MULLER ➤ Try a Free Trial
6,045,501 Coalition For Affordable Drugs VI LLC ➤ Try a Free Trial 2015-04-23 2015-04-23 Celgene Corporation Inter partes review ➤ Try a Free Trial 2015-10-27 MARC ELSAYED ➤ Try a Free Trial
6,315,720 Coalition for Affordable Drugs VI LLC ➤ Try a Free Trial 2015-04-23 2015-04-23 Celgene Corporation Inter partes review ➤ Try a Free Trial 2015-10-27 Bruce Williams ➤ Try a Free Trial
6,315,720 Coalition for Affordable Drugs VI LLC ➤ Try a Free Trial 2015-04-23 2015-04-23 Celgene Corporation Inter partes review ➤ Try a Free Trial 2015-10-27 Bruce Williams ➤ Try a Free Trial
6,315,720 Coalition for Affordable Drugs VI LLC ➤ Try a Free Trial 2015-04-23 2015-04-23 Celgene Corporation Inter partes review ➤ Try a Free Trial 2015-10-27 Bruce Williams ➤ Try a Free Trial
7,189,740 Dr. Reddy's Laboratories, Inc. ➤ Try a Free Trial 2018-08-03 2018-08-03 Zeldis, Jerome B. Inter partes review ➤ Try a Free Trial 2019-02-11 ➤ Try a Free Trial
Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
McKinsey
Chubb
Healthtrust
Federal Trade Commission
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.